Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5V9K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,925
Award facts
- Contract value 100% obligated
- $64,925.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $64,925.40 delivery order to AmerisourceBergen Drug Corp for 4,570,579,509 units of Dupixent 300 mg/2 ml pen injections, with an ultimate completion date of January 22, 2026. This firm fixed-price, non-set-aside contract was awarded on January 21, 2026, and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, representing critical pharmaceutical inventory for military and federal healthcare systems.
This delivery order operates under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. This comprehensive IDC enables the delivery of a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related healthcare commodities to support military treatment facilities and veterans' healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen competes on a full and open basis for contract awards, demonstrating its capability to meet government requirements for essential pharmaceutical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F5V9K?
SPE2DR26F5V9K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F5V9K worth?
The government has obligated $64,925 on SPE2DR26F5V9K.
Is contract SPE2DR26F5V9K an order under another contract?
Yes. SPE2DR26F5V9K is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5V9K competed?
The extent of competition for SPE2DR26F5V9K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award